The Future Of Drug Supply Monitoring In Europe (Poster)

his EMCDDA paper explores how better data can help us understand and respond to Europe’s illicit drug markets. Traditional indicators like seizures, prices, purity, and offences provide only part of the picture, so the agency is expanding its framework to include broader evidence on harms, market dynamics, and new data sources such as online activity.

Using drug prices as an example, the paper shows how changes in supply and demand, global events, and enforcement measures can all influence markets. By improving data quality and coverage across wholesale, retail, and import levels, EMCDDA aims to provide policymakers with clearer insights to guide effective, evidence-based responses.